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Chapter 5
SPLEEN AUTOTRANSPLANTATION PROVIDES RESTORATION
OF FUNCTIONAL SPLENIC LYMPHOID COMPARTMENTS AND
IMPROVES THE HUMORAL IMMUNE RESPONSE TO
PNEUMOCOCCAL POLYSACCHARIDE VACCINE
Leemans R*, Harms G†, Rijkers GT‡, Timens W.†
*Department of Surgery, Medical Centre, Leeuwarden, The Netherlands; † Department of 
Pathology, University Hospital, University of Groningen, NL-9700 RB Groningen, The Netherlands;
‡ Department of Immunology, University Hospital for Children and Youth ”Het Wilhelmina
Kinderziekenhuis”, Utrecht, The Netherlands. 
Clin Exp Immunology 1999; 117: 596-604.
Summary
After splenectomy, patients have an increased risk of overwhelming post-splenectomy
infection or sepsis involving encapsulated bacteria such as pneumococs. The value of
spleen autotransplantation after splenectomy because of trauma has long been questioned.
Much attention has been given to the restoration of mononuclear phagocyte system (MPS)
function, which appeared to be similar to that of splenectomized individuals. The presence
of specific anti-pneumococcal antibodies may enhance phagocytosis of opsonized 
bacteria by other parts of the MPS, as present in the liver. Therefore, in the present study
we have evaluated the restoration of the humoral immune response after spleen auto-
transplantation, especially to pneumococcal capsular polysaccharides (PPS).
Wistar rats were divided into three groups that were operated as follows: splenectomy,
splenectomy followed by autotransplantation, and sham operation. After 12 weeks the rats
were vaccinated with 23-valent pneumococcal vaccine. Blood samples were taken after 3
days, 3 and 6 weeks for anti-PPS IgM and IgG ELISA against types 3, 4, 6, 9, 14 and 23.
In addition, immunohistological studies were performed on the autotransplants.
Significant antibody titre rises were found in a main proportion of the autotransplanted
rats, comparable with sham-operated rats. Splenectomized rats showed as well 
significantly lower increase in Ig-levels, as significant differences in proportion of rats
showing a minimum 2-fold increase of antibody level, considered to represent an adequate
response. The titres were highest 3 days after vaccination. Immunohistochemical studies
demonstrated structurally functional autotransplants including an intact marginal zone.
Considering this significant anti-pneumococcal antibody response, spleen autotransplants
can be expected to enable an improved humoral response to PPS, and to contribute to
protection against OPSI after splenectomy.
Introduction
After splenectomy, patients have an increased risk of overwhelming post-splenectomy
infection (OPSI) or sepsis (OPSS). Such an infection has a high risk of mortality, 
especially in children1,2. Fatal OPSI is in most cases caused by pneumococci, the capsular
polysaccharides of which are considered to be T-cell-independent type 2 (TI-2) antigens.
It is known that the initiation of the antibody response to such antigens depends on the
presence of splenic tissue3, in particular a functional marginal zone B-cell compartment4,5.
Although spleen autotransplantation has been performed in an attempt to restore normal
spleen immune function, until now it has not been known whether autotransplants of
splenic tissue are capable of initiating a primary humoral reaction to TI-2 antigens. 
In animal experiments, focusing on the influence of the marginal zone of splenic 
transplants on the antibody response to TI-2 antigens, the restoration of the antibody titres
correlates with the return of B-cells, finally reaching titres indistinguishable from those of
normal mice6,7. In a recent study, it was shown that autotransplanted tissue in newborn rats
leads to a well-developed marginal zone and that this regenerated tissue provides 
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significant protection against pneumococcal infections introduced via the respiratory
tract8. In most human studies the function of autotransplants was only tested by functional
evaluation of the mononuclear phagocyte system (MPS)9,10,11. An example of detailed, 
adequate testing of specific splenic functions was given in a case report describing a
patient with extensive post-traumatic splenosis12. In most animal experiments using 
pneumococci or Pneumovax® only general antibody titres were evaluated, and not subtype
specific antibody titres9,13. The drawback of such an approach is that highly immunogenic
PPS-types may elicit a considerable response, thereby masking potential non-
responsiveness to other, less immunogenic types. Subsequently, the risk of OPSI in this
situation may still be present for the latter PPS-types.
In the present study we investigated the effect of splenic autotransplants on the antibody
responses to individual pneumococcal capsular polysaccharides of types 3, 4, 6, 9, 14 and
23. Antibody responses after vaccination with a pneumococcal capsular polysaccharide
vaccine were compared in sham-operated, splenectomized and spleen-autotransplanted
animals, respectively. To ensure full regeneration of white pulp in the splenic transplants,
vaccination was performed 12 weeks after operation. 
Materials and methods
Animals and operation
Male Wistar rats were housed under standard laboratory conditions on a 12-h light and
dark cycle. They were fed with standard laboratory rat food (Hope Farms, Inc, Woerden,
The Netherlands) and tap water ad libitum. Rats with a body weight of approximately 200
gr. of about three months of age were used for all experiments.
Sham operation (n = 10), splenectomy (n = 10) and splenic autotransplantation (n = 10)
were performed as described by Pabst et al.14. In short, all operations were performed via
an upper midline incision, under ether anaesthesia and clean but not sterile conditions. In
splenic autotransplantation the spleen was removed and half of the spleen tissue was cut
into pieces of approximately 1 mm3, which were sutured into an omental pouch. The
abdomen was closed in two layers.
Vaccination
For vaccination we used a 23-valent pneumococcal vaccine (Pneumovax®, Merck, Sharp,
and Dohme, West Point, PA, USA) which contains the PPS types 1, 2, 3, 4, 5, 6B, 7F, 8,
9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F. The sham
operated, splenectomized, and spleen-autotransplanted rats, (for all n=10) were 
vaccinated 12 weeks after operation. Vaccination was performed by intramuscular injec-
tion in the left hind leg with one dose (0.5 Fl) of Pneumovax®.
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Before vaccination (day 0) and 3 days, 3 weeks and 6 weeks after vaccination 500 µl
blood was taken from the retro-orbital plexus under mild anaesthesia.
Six weeks after vaccination the animals were sacrificed and spleen or spleen auto-
transplants, were obtained at autopsy. The spleens and the autotransplants were weighed
and tissue blocks were immediately frozen by immersion in liquid isopentane (cooled in a
freezer to -80°C) and stored in a freezer at -80°C until sectioning.
Anti-PPS ELISA
To detect the anti-PPS 3, 4, 6, 9, 14 and 23 IgM and IgG antibody titres in serum, a sand-
wich enzyme-linked immunosorbent assay was used as described previously15. In short,
ELISA plates were coated overnight at 37°C with 10 µg of PPS subtypes per ml in 0.9%
NaCl. Pooled serum from all sham-operated animals (n=10), immunised with Pneu-
movax® (day 21) was used as an internal reference and assigned 100 U/ml antibody for all
serotypes. To determine the anti-PPS concentrations in a given sample, serial dilutions
were titrated into the plate. Adsorption with pneumococcal cell wall polysaccharide (CPS)
was carried out by incubating serum samples overnight at 4°C with 50 µg of CPS (State
Seruminstitute, Copenhagen, Denmark) per ml. The ELISA was processed by adding 
peroxidase-conjugated goat anti-rat IgM or IgG (Tago, Burlingame, Calif.) and incubated
for 3 h at 37°C. Subsequently, the wells were allowed to react with 1.0 ml of 5.5 mM 
O-phenylenediamine-0.015% H2O2 in citrate phosphate buffer (pH 5). The yellow-brown
reaction product was measured after 10 to 15 min at 450 nm with an ELISA reader. 
Immunohistochemistry
To detect the different injected PPS-types16, we used group or type specific rabbit 
anti-pneumococcal polysaccharide (anti-PPS) antibodies (State Seruminstitute, 
Copenhagen, Denmark). As second step antibody we used a peroxidase conjugated Swine
anti-rabbit immunoglobulin (SARper; Dakopatts (Glostrup, Denmark). Kupffer cells in the
liver and red pulp macrophages in the spleen were stained using the mAb ED2, marginal
zone macrophages and metallophils in the spleen using mAb ED317 and as a B-lympho-
cyte marker the anti-IgM mAb His4018.
Cryostat sections (4 µm) were air dried for 20 min, fixed for 10 min in acetone, air dried
and washed in phosphate buffered saline (PBS) pH 7.4, for 5 min. Next, sections were
incubated for 30 min with an appropriately diluted type or group specific anti-PPS anti-
body directed against PPS-type 3 ,4 ,6 ,9 or 14 with 5% normal rat serum (NRS). 
Subsequently, sections were incubated with SARper diluted 1:20 in PBS with 5% NRS for
15 min. The peroxidase activity was visualised using 3-amino-9-ethylcarbazole (AEC)
and H2O2 as a reagent. Finally, sections were counterstained in Mayer’s hematoxylin and






The incidence of rats with ³ twofold rises of the antibody levels against pneumococcal
polysaccharides were analysed with the Fisher exact test. The increase of levels of the
antibodies in the different groups was compared using the Kruskal-Wallis and Mann-
Whitney test. P< 0.05 was taken as significant.
Results
Immunohistology of autotransplanted splenic tissue
Eighteen weeks after autotransplantation the splenic transplants showed a reduced weight.
The weight of the transplants was about 18% of the spleen weight in sham operated age
matched rats. As about half of the spleen was transplanted, this equals approximately 36%
Fig 1. Microphotographs (all immunoperoxidase staining) demonstrating restoration of spleen lymphoid
compartments including the functionally most relevant area, the marginal zone (12 weeks after
autotransplantation procedure). A. all B-cell areas stained with IgM antibody His40: overview (x40)
and B. magnification (x 100); C. marginal zone macrophages stained with ED3 (x 100). D. Staining
for PPS1: localisation in a dendritic pattern in the germinal centre; presumably on follicular 
dendritic cells. (X 100). 




of the originally implanted tissue weight. A clear demarcation of red and white pulp was
seen and the latter was positioned directly beneath the capsule. Central parts of the 
transplants still contained fibrotic tissue. A clear compartmentalisation in marginal zone,
mantle zone and germinal centre was detected with the anti-IgM mAb staining all 
B lymphocytes, and ED3 positive macrophages were present in the marginal zone. 
PPS-type 3, 4 and 9 but not PPS-type 6 and 14 were detected in the germinal centres in
most of the splenic transplants. The PPS were localised in a pattern consistent with 
localisation on follicular dendritic cells (FDC). None of the PPS types localised in the
marginal zone of the transplants, consistent with earlier kinetic studies, demonstrating that
PPS localise in vivo in the marginal zone at an early time point16, with a subsequent shift
in localisation to the follicle/germinal centre showing (from 3 days after immunisation) a
dendritic pattern. The above findings are illustrated in figure 1 (page 89).
Antibody responses
The IgM and IgG anti-PPS antibody response was studied in groups of animals that were
sham operated, splenectomized, or splenectomized and autotransplanted. IgM and IgG
anti-PPS antibody titres of the experimental groups in serum withdrawn before 
immunisation did not differ significantly from antibody titres in naive, non-immunised
rats. Day 0 was considered baseline for each group, and for the other time points (3, 21,
and 42 days after vaccination) the increase of PPS-type specific Ig level was determined in
comparison to this baseline level.
In figure 2 the mean values for both IgM and IgG are given for each time point relative to
baseline levels including standard deviations.
In sham-operated rats, immunisation with Pneumovax® induced a more than two-fold
increase in both IgM and IgG antibody titres against all pneumococcal serotypes tested.
The highest antibody titres were observed at day 3 after immunisation. At day 21, IgM
antibody titres against most serotypes had dropped to almost pre-immunisation levels
while IgG titres against serotypes 3, 4, and 9 still were higher than before immunisation
(compared with baseline: 2.1-, 3.3- and 3.7-fold increase, respectively).
Fig 2. (page 91-92-93)
Graphical representation of increase in PPS type-specific IgM and IgG between day 0 (day of 
vaccination) and A. day 3, B. day 21 and C. day 42, respectively. A. * increase in immunoglobulin
level significantly lower than sham-operated rats (* p<0.05; ** p<0.01). In B. and C. IgM levels are
all below a mean of 2-fold increase (minimum of 2-fold increase is considered clinically relevant).
For IgG at 21 days only for PPS9 is a relevant mean increase observed for the autotransplant group,
not different from the sham operated group, whereas the splenectomy group has significant lower
increase (p<0.05). For the other PPS no relevant increase was observed for either the splenectomy











In accordance with previous publications we found that splenectomy had a clearly 
negative effect on the anti-polysaccharide antibody response. At day 3 after immunisation
in splenectomized rats compared with sham operated rats, a significant lower antibody
titre was observed for all PPS types except PPS type 23 for both IgM and IgG (fig. 2). 
Splenectomy, followed by autotransplantation can partly rescue the antibody response to
Pneumovax® vaccination: at day 3 IgM response to PPS 3, 14 and 23, and IgG antibody
responses to pneumococcal serotypes 4, 6, 9, and 23 were similar in the autotrans-
plantation group as compared with the sham-operated group. 
When evaluating the number of rats in each group reaching ³ two-fold increase in
immunoglobulin titres, compared with the sham-operated group (fig. 3), both at day 3 and
day 21, the splenectomy group showed a significant lower relative number of adequate
responders for all PPS types except PPS14 for IgM and for all but PPS3 for IgG (p< 0.05). 
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Fig 3. Graphical representation of number of rats per group with minimum of 2-fold increase in PPS 
type-specific IgM and IgG between day 0 (day of vaccination) and day 3. (Significant lower num-
bers compared to sham-operated rats: * p<0.05; # p= 0.05)
In contrast, for the autotransplanted group for IgM only for PPS4 and 6 and for IgG only
for PPS3 and 4 was a lower number of responders found, both at day 3 and day 21. No 
other immunoglobulin titres were significantly different from the sham operated group. At
day 42 only individual rats in the splenectomy and autotransplantation group showed
more than two-fold increase in immunoglobulin titre, whereas the sham operated rats
showed >2-fold responses for IgG levels for PPS4 (three rats), PPS9 (five rats) and PPS14
(two rats).
Discussion
Reimplantation of splenic tissue has been postulated to account for a lower incidence of
OPSI among patients splenectomized for trauma8,19. However, the efficacy of splenic auto-
transplantation in restoring the immune response after splenectomy has not yet been 
established firmly. Some studies support the notion that immunisation combined with auto-
transplantation leads to higher antibody levels and may therefore offer a survival benefit20.
In this study it is demonstrated that autotransplantation followed by vaccination confers the
ability to mount an improved IgM and IgG antibody response to pneumococcal capsular
polysaccharide antigens. Restoration of the early IgM response after vaccination is not the
most surprising, as TI-2 antigens that enter the bloodstream will normally localise in the
spleen followed by a rapid IgM response21. The IgG results are concurrent with earlier
reports22 and with the fact that in humans, a single vaccination with Pneumovax® induces
significant levels of IgG antibodies. Although the early IgG response might be the 
consequence of a classic secondary immune response, the non- or low-responsiveness for
most PPS subtypes after splenectomy does indicate that this is not likely. In previous 
studies we have demonstrated that localisation of PPS on follicular dendritic cells in 
follicle and germinal centre is dependent on a serum factor, most likely a complement-
fragment (probably C3d), but not on the presence of specific antibody16,23,24. This implies
that PPS after entering the marginal zone, may induce PPS-specific B-cells migrating to the
follicle/germinal centre16,25,26, where PPS-complement complexes at the same moment are
already localised on FDC16,23,24. The germinal centre is considered to be the area where the
isotype-switch takes place, enabled by immune complexes on local follicular dendritic
cells. Tentatively, it can be suggested that specific for this type of antigen an early isotype
switch to IgG can take place independently of the presence of substantial levels of specific
IgM. 
It should be noted that the clinical presentation of a pneumococcal infection in 
splenectomized patients (i.e. pneumococcal sepsis) is unlike that of other patients with
increased susceptibility to pneumococcal infections due to insufficient anti-poly-
saccharide antibodies. In the latter category of patients, pneumococcal infections may
cause pneumonia, meningitis or otitis, but seldom results in sepsis. This can be explained,
because when a functional spleen is present, even badly opsonized pneumococci can be
cleared by the spleen MPS, due to the specific low flow spleen red pulp architecture21 thus
preventing bacteremia and sepsis. As in the case of splenectomy the restoration of 
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clearance by autotransplantation is insufficient11, and restoration of the humoral response
becomes even more important, allowing good opsonization of PPS.
Despite the observation of normal total IgM or IgG antibody titres against TI-2 antigens, a
low or absent response to individual subtypes may be present. The capacity for an early,
adequate humoral response is of utmost importance, as in case of pneumococcal 
bacteremia with risk of sepsis, only protection can be expected when a rapid humoral
response can be elicited. Only in this case the bacteria may be opsonized. When small
amounts of regenerated autotransplanted spleen are present, with adequate response
capacities to TI-2 antigen, specific antibodies will be formed. These antibodies are able to
cause opsonization of the antigen (encapsulated bacteria) and, because phagocytosing
capacity of the splenic fragments will not play an important role, the cells of the mono-
nuclear phagocyte system as present in the liver are then capable of removing these
opsonized particles21.
The architecture of the splenic transplants demonstrated that we were dealing with
regenerated splenic fragments with a largely restored white pulp. A functional white pulp
is characterised by follicles with a functional germinal centre and a distinct marginal zone
that is occupied with B lymphocytes, capable of inducing a primary immune response
against TI-2 antigens in an appropriate vascular micro-environment. From the extensive
studies by Pabst and co-workers, it was concluded that the younger the recipient and the
donor, the better the regeneration and perfusion of the regenerated splenic tissue27,28. In
addition to these results which showed mainly adequate regeneration when using
fetal/newborn spleens, we obtained similar results using rats of 3 months old 
(”adolescent”). This may be due to strain differences. Although for the human situation an
estimation of age range, probably limiting the success of spleen autotransplantation, is
hard to give, it seems likely that there is a much better potential for splenic regeneration in
children and possibly young adults, than in older subjects.
The question how much spleen tissue should be transplanted has been a matter of 
controversy with respect to both total amount of transplanted tissue and size of the
individual spleen fragments9,19. In different animal models the implanted amount of spleen
tissue did not affect the resulting amount of regenerated tissue, whereas a particle size
does seem to play a role27. Others and we think that particle size should at least allow the
reticular/stromal structures of individual white pulp nodules to remain intact27 and should
allow ingrowth of proliferating vessels at the implantation site. Although a minimum
amount of transplanted spleen tissue seems necessary, a too large mass will result in
increase of necrosis, resulting in fever and other complications.
In our study the response capacity was evaluated 12 weeks after transplantation, as for rats
it was reported27 that regeneration of spleen transplants was in general completed. For 
other species it may take more time to complete this regeneration; 3-6 months is supposed
to be the maximum time frame in which regeneration is completed. At present it is not
known whether at this time point also functional maturation is reached, although from our
results it appears that at least an initial capability to respond to TI-2 antigens is present.
Future studies should reveal whether improvement of immune responses could be
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obtained when postponing the antigen challenge.
The conclusion of this study is that autotransplanted splenic tissue in the omentum major
after splenectomy has the possibility to grow out to immunological functioning spleens
with a functional marginal zone. Consequent on this we demonstrated the capacity of 
early specific antibody formation in the autotransplanted rats comparable to normal,
whereas after splenectomy a significantly decreased response was observed for most 
PPS-types. Autotransplantation followed by immunisation after a time interval will lead to
significant increase of antibody levels for most PPS types in most subjects comparable to
sham operated rats, whereas after splenectomy a significantly lower number of subjects
show a relevant increase in antibody levels. In particular because high immunoglobulin
levels are already found at an early time point (3 days) this may give protection against
OPSI and offer a survival benefit. Although this has also to be proven in humans, these
findings are a positive argument that autotransplantation of splenic tissue is of value and
may provide protection against OPSI.
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